Test Price
2,800 AED✅ Home Collection Available
MYL2 Gene Familial Hypertrophic Cardiomyopathy Type 10 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
This advanced genetic test provides definitive diagnosis for MYL2‑related hypertrophic cardiomyopathy with 99.9% analytical sensitivity, conducted in our ISO‑accredited laboratory. Logistics include VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, available daily from 8 AM to 11 PM. Post‑result telephonic clinical guidance is included. Direct billing verification via WhatsApp +971 54 548 8731.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The MYL2 gene NGS test identifies pathogenic variants causing familial hypertrophic cardiomyopathy type 10, enabling precise diagnosis and family screening. The test uses next‑generation sequencing (NGS) to cover the entire coding region of the MYL2 gene, detecting missense, nonsense, splice‑site, and small insertions/deletions.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% Sensitivity, Complete MYL2 Coverage | 94% Sensitivity, Hotspot Panel |
| Method | Next‑Generation Sequencing (NGS) | Sanger Sequencing (Single Variant) |
| Speed | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I understand the profound impact a cardiomyopathy diagnosis can have on families. This MYL2 gene test clarifies the genetic basis of hypertrophic cardiomyopathy, guiding tailored surveillance and cascade screening. Remember: results must always be interpreted in the full clinical context; a negative result does not exclude disease, and a positive result warrants multidisciplinary care including cardiology and genetics.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Advisory: Medication Continuity
Important: Do not discontinue any prescribed cardiac medication without explicit consultation with your treating physician. The genetic test does not replace ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Not for asymptomatic minors without parental consent as per UAE Medical Liability Law.
- If you have experienced syncope, chest pain, or severe shortness of breath in the last 48 hours, seek immediate emergency care before scheduling.
- Specimen collection should be deferred if you are febrile (>38.5°C) or acutely unwell.
- Pregnancy is not a contraindication, but inform the phlebotomist.
Patient FAQ & Clinical Guidance
1. What does the MYL2 genetic test detect and how accurate is it?
Snippet: This NGS test detects all pathogenic variants in the MYL2 gene with 99.9% sensitivity, essential for diagnosing familial hypertrophic cardiomyopathy type 10. It sequences the entire coding region to identify missense, nonsense, and splice-site mutations that cause protein dysfunction. Results guide risk stratification in relatives.
2. How is the sample collected and what is the turnaround time?
Snippet: A single blood draw, extracted DNA, or one drop of blood on an FTA card is required; results are available in 3–4 weeks. Our VIP home collection team ensures sample integrity with cold-chain logistics, and you can schedule via WhatsApp at any time between 8 AM and 11 PM.
3. Is this covered by insurance and what legal protections apply?
Snippet: We offer direct billing verification and most UAE insurers cover genetic testing with a valid medical necessity; privacy is guaranteed under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Genetic data is protected and we never share results without explicit consent. A genetic counselling session is included to interpret your results securely.
UAE Regulatory & Data Privacy Adherence
This genetic test is performed at DNA Labs UAE in full compliance with UAE federal laws:
- Personal Data Protection: Federal Decree-Law No. 45 of 2021 (PDPL) governs the collection, processing, and storage of your genetic and personal data.
- Health Information Technology: Federal Law No. 2 of 2019 ensures the secure use of ICT in health fields, including electronic health records and telemedicine.
- Medical Liability: Federal Decree-Law No. 4 of 2016 on Medical Liability ensures patient safety and consent protocols during sample collection and result disclosure.
All data is encrypted, stored in the UAE, and never shared without your written consent. Direct billing verification is available through our WhatsApp line.
Clinical & Logistical Metadata
| Test Name | MYL2 Gene Familial Hypertrophic Cardiomyopathy Type 10 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube), extracted DNA, or dried blood spot (FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Whole Exome Sequencing with targeted MYL2 analysis |
| ICD-10-CM Code | I42.1 (Hypertrophic cardiomyopathy) |
| LOINC Code | 93172-3 (MYL2 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians